DaVita Venture Group is dedicated to investing in and partnering with innovators to provide strategic capital aimed at improving the lives of patients with kidney disease. They focus on various investment priorities including care models, digital health, new service lines, and life sciences. Their capabilities span venture capital, corporate development, and strategic partnerships.
| Fund Size | N/A USD |
| Stages Focus | Pre-Seed, Seed, Series A, Series B, Series C |
| Sectors Focus | Healthcare, Biotech, Medical Devices, Diagnostics |
| Portfolio Size | 4 companies |
DaVita Venture Group's investment thesis is centered on revolutionizing healthcare, with a particular focus on improving the lives of patients with kidney disease. They seek to invest in and partner with innovators across various stages and sectors that align with their mission to drive clinical excellence and enhance patient outcomes.
Target Founders: Innovators in healthcare technology and services
Sectors: Care Models, Digital Health, New Service Lines, Life Sciences
Stage: Stage agnostic, up to $10M
Check Size: Up to $10M
Deal Criteria: Innovations that improve patient outcomes and reduce costs
Active team contains 18 members (4 partners, 0 founders).
DaVita Venture Group is a venture capital firm dedicated to investing in and partnering with innovators to provide strategic capital aimed at improving the lives of patients with kidney disease.
DaVita Venture Group operates globally.
This information is not publicly available.
DaVita Venture Group is a venture capital firm.
Yes, DaVita Venture Group invests in the Healthcare sector.
Yes, DaVita Venture Group invests in the Biotech sector.
Yes, DaVita Venture Group invests in the Medical Devices sector.
Yes, DaVita Venture Group invests in the Diagnostics sector.
Yes, DaVita Venture Group invests in the Pre-Seed stage.
Yes, DaVita Venture Group invests in the Seed stage.